The brain operates around the clock. Even during deep sleep, it remains active and undergoes restoration, and all this work results in a buildup of waste proteins that need to be cleared.
For a long time, researchers believed they had a precise map of where these waste products went. They constructed this map by tracking the fluid that carries the waste, rather than the waste itself. Now, a new study has redrawn that map.
The research behind this effort comes from the lab of Andrew Yang, a researcher at the Gladstone Institute in San Francisco. His team aimed to understand how waste proteins generated deep within the brain are eliminated. The findings of their study have been published in the journal Cell.
For decades, scientists would inject a dye into cerebrospinal fluid—the clear fluid that cushions the brain—and observe its flow. This approach illuminated all potential exits, not just those utilized by the brain itself. While useful, it was an imprecise method.
“The tracers we injected were altering the very system we were trying to measure,” Yang stated.
The solution was to follow the waste, not the fluid transporting it. His team genetically modified neurons—the nerve cells of the brain—in mice to produce a protein called ZsGreen, which emits a bright green fluorescence.
Because the cells were generating this marker themselves, the team could track it as a byproduct of cellular waste. The fluorescent protein appeared in tissues located just outside the brain: within its tough outer membrane, the skull, and the nasal passages.
The first surprise was where the waste didn’t go.
A landmark study a decade ago concluded that molecules cleared from the brain drained into lymph nodes in the neck, and ever since, researchers have considered these nodes the primary route for brain waste removal.
However, tracking the fluorescent protein revealed a different story. Very little of it reached the neck lymph nodes. Instead, most of it flowed out through the brain’s dense membrane, the skull, and the nasal passages.
This discrepancy validated the team’s suspicions. Observing the fluid shows where it can go; observing the proteins shows where they actually end up.
For the first time, researchers were able to directly compare these two phenomena.
A second pattern surprised the team even more, and it was based on location. Proteins produced in the upper parts of the brain exited through upper pathways, while proteins from deeper regions used routes closer to the base. Each region seemed to have its own distinct exit.
The researchers have termed this the “nearest exit” model. Co-author Nalini Rao suggests that these built-in pathways might degrade over time or due to disease, leading to waste accumulation in unintended areas.
If these routes become compromised, some regions might experience a failure in their drainage system sooner than others. This could potentially explain why diseases like Alzheimer’s disproportionately affect certain brain areas while sparing others, though the team currently views this as a hypothesis.
The speed of clearance varied among the different exit routes. The fluorescent protein was rapidly eliminated through the brain’s membrane and nasal passages, but it lingered in the skull, exiting slowly over a much longer period.
Upon closer examination of the brain’s boundaries, researchers found immune cells present that retained the proteins and analyzed them as they passed. The slower outflow near the skull appeared to serve a purpose.
This extended contact may give these immune cells time to examine the brain proteins and identify them as benign, rather than foreign invaders. If this is the case, some of what appears to be waste might be performing a secondary function on its way out.
“Neurons are constantly making proteins, and as those proteins leave the brain, some of them may be helping to educate our immune system,” Rao remarked.
This idea challenges the simple notion that the brain merely discards what it no longer needs.
Disease impacted the system in two contrasting ways. In mice experiencing sudden, severe inflammation—akin to what a serious infection might cause—the fluorescent protein deviated from its normal path and entered the bloodstream directly.
In a mouse model of Alzheimer’s disease, the failure was reversed. The protein accumulated within the brain and could not be cleared effectively, creating a backlog that allowed toxic proteins to build up.
As the study demonstrated, such clearance disruptions occur early in disease progression. These failures point to potential targets for future therapies. If clinicians could intervene in the brain’s boundary tissues, they might be able to restore drainage pathways blocked by disease and slow the accumulation of harmful proteins.
Before this research, no one could track the journey of brain waste from the cell that produced it to its ultimate exit point. This work now offers the ability to do just that: to directly study the brain’s natural waste disposal system for the first time.
This tool has already revealed that the brain sorts its waste based on its location and clears it at varying rates. Some of this exiting protein may even contribute to training the body’s immune defenses. Yang’s group now intends to explore how aging affects these pathways and whether sleep indeed helps clear the brain, as previous research suggested.
A more significant reward lies in gaining a clearer understanding of why clearance fails. With the drainage routes finally mapped, researchers can now investigate whether worn-out drainage systems contribute to disease development in aging brains. They can also explore whether brain tumors exploit these exit pathways to stealthily evade the immune system.
About the Author
